---
# the default layout is 'page'
layout: page
icon: fas fa-info-circle
order: 4
---

## üìñ Education

### üéì Degree

- Ph.D. of Biology, 2022-2028 (expected), School of Basic Medical Sciences, Fudan University, Shanghai, China

  - Major: Metabolism and Diseases, Biochemistry and Molecular Biology
  - Programme: Successive postgraduate and doctoral programme
  - Research interests: Cancer Research; Bioinformatics; Human Microbiome
  - Academic advisor: Dr. Zhao Zhang

- B.Sc. of Biology, 2016-2021, College of Informatics, Huazhong Agricultural University, Wuhan, China

  - Major: Bioinformatics
  - Graduation project: Benchmarking imputation algorithms in scRNA-seq analysis
  - Academic advisor: Dr. Qianqian Shi
 
### üèõÔ∏è Visiting and exchanging

- Visiting Student, 2019, School of Life Science, The Chinese University of Hong Kong, Hong Kong, China

  - Programme: Biological and Biomedical Science Programme
  - Research topic: The mechanism and clinical applications of siRNAs

## üìë Publication

Marks: Co-first author* and corresponding author#.

- As the first and co-first author
  - <span style="color:cyan">**Wang Y.**</span>, ..., Zhang Z.#, & Han L.# [Characterization of Tumor Antigens from Multi-omics Data: Computational Approaches and Resources.](https://doi.org/10.1093/gpbjnl/qzaf001) *Genomics, Proteomics & Bioinformatics* qzaf001 (2025).
  - Yuan L.*, Pan L.*, <span style="color:cyan">**Wang Y.‚Ä†**</span>, ..., Zhang Z.#, & Cheng X.# [Characterization of the landscape of the intratumoral microbiota reveals that Streptococcus anginosus increases the risk of gastric cancer initiation and progression.](https://doi.org/10.1038/s41421-024-00746-0) *Cell Discov* 10, 117 (2024).
  - <span style="color:cyan">**Wang Y.**</span>, ..., & Zhang Z.# [Enhancer RNA (eRNA) in Human Diseases.](https://doi.org/10.3390/ijms231911582) *Int. J. Mol. Sci.* 23, 11582 (2022).

- As contributing author
  - Zhang C.*, Chen Y.*, Chen S., <span style="color:cyan">**Wang Y.**</span>, ..., & Zhang Z.# [Characterization of an Enhancer RNA Signature Reveals Treatment Strategies for Improving Immunotherapy Efficacy in Cancer.](https://doi.org/10.1158/0008-5472.CAN-24-2289) *Cancer Res* 3, 85 (2025).
